Botulinum Toxin Type B Blocks Sudomotor Function Effectively: A 6 Month Follow Up

This publication has 16 references indexed in Scilit:

• Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin
  Zeitschrift für Neurologie, 2003
• Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies
  Annals of Neurology, 2002
• Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)
  New England Journal of Medicine, 2001
• Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry
  British Journal of Dermatology, 2001
• Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A?A preliminary observation
  Movement Disorders, 2000
• Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
  Neurology, 1999
• Mouse bioassay versus Western blot assay for botulinurn toxin antibodies Correlation with clinical response
  Neurology, 1998
• Sudomotor function in sympathetic reflex dystrophy
  Pain, 1997
• Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
  Muscle & Nerve, 1997
• Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia
  Neurology, 1993